The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses

FEBS Letters

Volumn 588, Issue 17, 2014, Pages 3154-3159

  Moscardo A ^a   Valles J ^b   Latorre, A ^a   Santos, M T ^b  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Lipid raft; Platelet; Signal transduction; Thromboxane receptor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [3 HYDROXY 4 (4 IODOPHENOXY) 1 BUTENYL] 7 OXABICYCLO[2.2.1]HEPTAN 2 YL] 5 HEPTENOIC ACID; CALCIUM ION; CHOLESTEROL; INTEGRIN; INTEGRIN ALPHA2B BETA3; PADGEM PROTEIN; PURINERGIC P2Y12 RECEPTOR; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; CALCIUM; THROMBOXANE A2; THROMBOXANE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; LIPID RAFT; LIPOLYSIS; NUCLEOTIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOXANE A(2);

LIPID RAFT; PLATELET; SIGNAL TRANSDUCTION; THROMBOXANE A(2); THROMBOXANE RECEPTOR;

BLOOD PLATELETS; CALCIUM; CYTOSOL; HUMANS; MEMBRANE MICRODOMAINS; PLATELET ACTIVATION; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; THROMBOXANE A2;

EID: 84906242137     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.06.057     Document Type: Article

References (26)

1. C. Baigent, C. Sudlow, R. Collins, and R. Peto Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ. 324 2002 71 86
2. S. Offermanns Activation of platelet function through G protein-coupled receptors Circ. Res. 99 2006 1293 1304
3. A. Moers, B. Nieswandt, S. Massberg, N. Wettschureck, S. Gruner, I. Konrad, V. Schulte, B. Aktas, M.P. Gratacap, M.I. Simon, M. Gawaz, and S. Offermanns G13 is an essential mediator of platelet activation in hemostasis and thrombosis Nat. Med. 9 2003 1418 1422
4. J.A. Lopez, I. Del Conde, and C.N. Shrimpton Receptors, rafts, and microvesicles in thrombosis and inflammation J. Thromb. Haemost. 3 2005 1737 1744
5. A.V. Samsonov, I. Mihalyov, and F.S. Cohen Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes Biophys. J. 81 2001 1486 1500
6. S. Bodin, H. Tronchere, and B. Payrastre Lipid rafts are critical membrane domains in blood platelet activation processes Biochim. Biophys. Acta 1610 2003 247 257
7. B. Chini, and M. Parenti G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J. Mol. Endocrinol. 32 2004 325 338
8. S. Goto, M. Saito, Y. Obara, T. Moriya, and N. Nakahata Involvement of lipid rafts in multiple signal transductions mediated by two isoforms of thromboxane A2 receptor: dependency on receptor isoforms and downstream signaling types Eur. J. Pharmacol. 693 2012 15 24
9. S. Ibrahim, A. McCartney, N. Markosyan, and E.M. Smyth Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts Arterioscler. Thromb. Vasc. Biol. 33 2013 60 66
10. M.T. Santos, A. Moscardo, J. Valles, M. Martinez, M. Pinon, J. Aznar, M.J. Broekman, and A.J. Marcus Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha (IIb) beta (3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets Circulation 102 2000 1924 1930
11. Y. Ezumi, K. Kodama, T. Uchiyama, and H. Takayama Constitutive and functional association of the platelet collagen receptor glycoprotein VI-Fc receptor gamma-chain complex with membrane rafts Blood 99 2002 3250 3255
12. J. Valles, M.T. Santos, J. Aznar, A.J. Marcus, V. Martinez-Sales, M. Portoles, M.J. Broekman, and L.B. Safier Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment Blood 78 1991 154 162
13. A. Moscardo, J. Valles, M. Pinon, J. Aznar, V. Martinez-Sales, and M.T. Santos Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets Platelets 17 2006 405 415
14. D.J. Dorahy, L.F. Lincz, C.J. Meldrum, and G.F. Burns Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36 Biochem. J. 319 Pt 1 1996 67 72
15. S.J. Shattil, M. Cunningham, and J.A. Hoxie Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry Blood 70 1987 307 315
16. R.T. Dorsam, S. Kim, J. Jin, and S.P. Kunapuli Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets J. Biol. Chem. 277 2002 47588 47595
17. T.M. Quinton, S. Kim, J. Jin, and S.P. Kunapuli Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation J. Thromb. Haemost. 3 2005 1036 1041
18. P. Savi, J.L. Zachayus, N. Delesque-Touchard, C. Labouret, C. Herve, M.F. Uzabiaga, J.M. Pereillo, J.M. Culouscou, F. Bono, P. Ferrara, and J.M. Herbert The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts Proc. Natl. Acad. Sci. U.S.A. 103 2006 11069 11074
19. A. Moscardo, M.T. Santos, M.P. Fuset, M. Ruano, and J. Valles Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction Thromb. Haemost. 105 2011 663 669
20. S. Murugappan, H. Shankar, and S.P. Kunapuli Platelet receptors for adenine nucleotides and thromboxane A2 Semin. Thromb. Hemost. 30 2004 411 418
21. P. Lova, S. Paganini, F. Sinigaglia, C. Balduini, and M. Torti A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets J. Biol. Chem. 277 2002 12009 12015
22. K. Gousset, W.F. Wolkers, N.M. Tsvetkova, A.E. Oliver, C.L. Field, N.J. Walker, J.H. Crowe, and F. Tablin Evidence for a physiological role for membrane rafts in human platelets J. Cell Physiol. 190 2002 117 128
23. M.T. Santos, J. Valles, A. Lago, J. Tembl, E. Sanchez, A. Moscardo, and J. Cosin Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease J. Thromb. Haemost. 6 2008 615 621
24. H.J. Ting, J.P. Murad, E.V. Espinosa, and F.T. Khasawneh Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting J. Cardiovasc. Pharmacol. Ther. 17 2012 248 259
25. A. Habib, G.A. FitzGerald, and J. Maclouf Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets J. Biol. Chem. 274 1999 2645 2651
26. K. Kasahara, M. Kaneda, T. Miki, K. Iida, N. Sekino-Suzuki, I. Kawashima, H. Suzuki, M. Shimonaka, M. Arai, Y. Ohno-Iwashita, S. Kojima, M. Abe, T. Kobayashi, T. Okazaki, M. Souri, A. Ichinose, and N. Yamamoto Clot retraction is mediated by factor XIII-dependent fibrin-alphaIIbbeta3-myosin axis in platelet sphingomyelin-rich membrane rafts Blood 122 2013 3340 3348